SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/6/2016 11:44:47 AM - Followers: 1 - Board type: Free - Posts Today: 0

Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States 484-324-7933 http://www.aclaristx.com Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ACRS News: Amended Statement of Ownership (sc 13g/a) 02/15/2017 07:09:07 AM
ACRS News: Statement of Ownership (sc 13g) 02/14/2017 05:58:09 PM
ACRS News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 10:43:40 AM
ACRS News: Amended Statement of Ownership (sc 13g/a) 02/08/2017 03:47:03 PM
ACRS News: Aclaris Therapeutics to Attend Upcoming Investor Conferences 02/06/2017 04:08:00 PM
PostSubject
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM
PostSubject